Method Development and Validation for Ophthalmic Formulations Containing Antibiotics: A Comprehensive Review

被引:0
|
作者
Thapar, Shipra [1 ]
Chawla, Anshul [1 ]
Gupta, G. K. [2 ]
机构
[1] CT Coll Pharm, Dept Pharmaceut Sci, Jalandhar 144020, Punjab, India
[2] Sri Sai Coll Pharm, Dept Pharmaceut Chem, Pathankot 145001, Punjab, India
关键词
Antibiotic; conjunctivitis; method development; pink eye; validation; ACUTE BACTERIAL CONJUNCTIVITIS; LIQUID-CHROMATOGRAPHIC METHOD; HPLC METHOD; TOPICAL ANTIBIOTICS; EYE DROPS; DIAGNOSIS; GATIFLOXACIN;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bacterial conjunctivitis commonly referred to as pink eye, having an inflammation of the conjunctiva either due to infection or an allergic condition. The outer lining of the white part of our eye gets reddish or pink in color. Ophthalmic antibiotics are instilled for curing this condition. Many ophthalmic formulations are available in the market for curing this condition. Most of them contain an antibiotic along with a steroidal moiety. Method development plays a pivotal role in drug testing, manufacturing operations, stability studies and the long term performance of drugs. International Council for Harmonisation provides guidelines for validating analytical methods. With minimal use of time and money scientists all over the world are developing new methods for the same. Several studies have already been done for the method development of such ophthalmic solutions but still, some antibiotics remain untouched. This review article emphasizes detailed information regarding the methods developed for ophthalmic formulations and their validation as well.
引用
收藏
页码:555 / 564
页数:10
相关论文
共 50 条
  • [1] Development and Validation of a Discriminating In Vitro Dissolution Method for Oral Formulations Containing Satranidazole
    Pawar, Harshal Ashok
    Joshi, Pooja Rasiklal
    INTERNATIONAL JOURNAL OF SPECTROSCOPY, 2014,
  • [2] Development and Characterization of Thermosensitive and Bioadhesive Ophthalmic Formulations Containing Flurbiprofen Solid Dispersions
    Adisanoglu, Pinar
    Ozguney, Isik
    GELS, 2024, 10 (04)
  • [3] ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF TRICLOSAN IN DENTAL FORMULATIONS
    Mahitha, P.
    Gurupadayya, B. M.
    Chandan, R. S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (09): : 3810 - 3816
  • [4] Development and Validation of HPTLC Method for Estimation of Tacrolimus in Formulations
    Borhade, Vivek Baban
    Nair, Hema Ajit
    Hegde, Darshana Deepak
    Barhate, Chandrashekhar R.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (04) : 440 - 448
  • [5] Development and Validation of an HPTLC Method for Determination of Olanzapine in Formulations
    Patel, Rashmin B.
    Patel, Mrunali R.
    Bhatt, Kashyap K.
    Patel, Bharat G.
    JOURNAL OF AOAC INTERNATIONAL, 2010, 93 (03) : 811 - 819
  • [6] Development and validation of a spectrofluorimetric method for the estimation of rivastigmine in formulations
    Kapil, R.
    Dhawan, S.
    Singh, Bhupinder
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 71 (05) : 585 - 589
  • [7] Excipients in drug delivery systems: A comprehensive review of approved inactive ingredients for human ophthalmic formulations
    Arribada, Raquel Gregorio
    Rodrigues-Braz, Daniela
    Silva-Cunha, Armando
    Behar-Cohen, Francine
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2025, 208
  • [8] Development of an Ex Vivo Method for Evaluation of Precorneal Residence of Topical Ophthalmic Formulations
    Liu, Quan
    Wang, Youmin
    AAPS PHARMSCITECH, 2009, 10 (03): : 796 - 805
  • [9] Development of an Ex Vivo Method for Evaluation of Precorneal Residence of Topical Ophthalmic Formulations
    Quan Liu
    Youmin Wang
    AAPS PharmSciTech, 2009, 10 : 796 - 805
  • [10] HPTLC methods to assay active ingredients in pharmaceutical formulations: A review of the method development and validation steps
    Shewiyo, D. H.
    Kaale, E.
    Risha, P. G.
    Dejaegher, B.
    Smeyers-Verbeke, J.
    Vander Heyden, Y.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 66 : 11 - 23